Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline describes STING modulators

Dec. 31, 2015

Bristol-Myers Squibb patents MGAT2 inhibitors

Dec. 31, 2015

Shionogi reports development of antifungal agents

Dec. 30, 2015

Takeda Pharmaceutical divulges muscarinic M1 PAMs

Dec. 30, 2015

Adamed develops p53-MDM2 interaction inhibitors

Dec. 30, 2015

Kyoto Pharmaceutical Industries reports napabucasin prodrugs

Dec. 30, 2015

Bristol-Myers Squibb presents nAChR alpha7 agonists

Dec. 30, 2015

French scientists describe GPBAR1 agonists

Dec. 30, 2015

Nanjing Sanhome Pharmaceutical patents EGFR inhibitors

Dec. 30, 2015

Max-Planck-Gesellschaft patent details PDE inhibitors

Dec. 29, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...